PA
PFE icon

Procyon Advisors’s Pfizer PFE Stock Holding History

Procyon Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
55,347
+1,599
+3% +$41.8K 0.06% 244
2026
Q1 		$1.51M Buy
53,748
+410
+0.8% +$10.9K 0.07% 222
2025
Q4 		$1.33M Sell
53,338
-5,325
-9% -$134K 0.07% 234
2025
Q3 		$1.49M Sell
58,663
-33
-0.1% -$815 0.09% 182
2025
Q2 		$1.42M Sell
58,696
-19,895
-25% -$464K 0.13% 145
2025
Q1 		$1.95M Buy
78,591
+23,020
+41% +$602K 0.12% 175
2024
Q4 		$1.47M Sell
55,571
-576
-1% -$15.6K 0.09% 202
2024
Q3 		$1.63M Buy
56,147
+329
+0.6% +$9.6K 0.11% 185
2024
Q2 		$1.56M Sell
55,818
-3,182
-5% -$87.6K 0.12% 176
2024
Q1 		$1.64M Sell
59,000
-3,111
-5% -$86.3K 0.13% 175
2023
Q4 		$1.79M Sell
62,111
-16,524
-21% -$500K 0.15% 154
2023
Q3 		$2.61M Buy
78,635
+33,196
+73% +$1.17M 0.27% 93
2023
Q2 		$1.67M Buy
45,439
+14,553
+47% +$566K 0.21% 109
2023
Q1 		$1.26M Buy
30,886
+2,572
+9% +$111K 0.21% 114
2022
Q4 		$1.45M Buy
28,314
+5,464
+24% +$262K 0.27% 87
2022
Q3 		$1M Sell
22,850
-1,939
-8% -$94.2K 0.24% 94
2022
Q2 		$1.3M Sell
24,789
-2,929
-11% -$149K 0.29% 84
2022
Q1 		$1.44M Buy
27,718
+325
+1% +$16.9K 0.3% 74
2021
Q4 		$1.62M Sell
27,393
-2,457
-8% -$122K 0.34% 67
2021
Q3 		$1.28M Sell
29,850
-8,688
-23% -$385K 0.33% 73
2021
Q2 		$1.51M Buy
38,538
+22,936
+147% +$892K 0.41% 62
2021
Q1 		$565K Sell
15,602
-210
-1% -$7.46K 0.25% 93
2020
Q4 		$582K Buy
15,812
+1,384
+10% +$50.8K 0.28% 90
2020
Q3 		$502K Buy
14,428
+1,966
+16% +$68.9K 0.28% 90
2020
Q2 		$387K Buy
12,462
+1,497
+14% +$50.9K 0.21% 103
2020
Q1 		$340K Sell
10,965
-1,058
-9% -$36.1K 0.23% 92
2019
Q4 		$447K Buy
+12,023
New +$428K 0.27% 85

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Procyon Advisors's PFE Position: Q2 2026 in Review

Procyon Advisors increased its Pfizer (PFE) stake by 3% in Q2 2026, buying an estimated $41.8K and bringing the position to 55,347 shares worth $1.33M. The position accounts for 0.06% of the portfolio, ranked #244.

Procyon Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.61M in Q3 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Procyon Advisors held 55,347 shares of Pfizer worth $1.33M as of Q2 2026.
  • Procyon Advisors bought 1,599 Pfizer shares in Q2 2026, an estimated $41.8K.
  • Pfizer made up 0.06% of Procyon Advisors's portfolio in Q2 2026, its #244 holding.
  • Procyon Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Pfizer position peaked at $2.61M in Q3 2023.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.